Cargando…
A novel epigenetic signature for overall survival prediction in patients with breast cancer
BACKGROUND: Breast cancer is the most common malignancy in female patients worldwide. Because of its heterogeneity in terms of prognosis and therapeutic response, biomarkers with the potential to predict survival or assist in making treatment decisions in breast cancer patients are essential for an...
Autores principales: | Bao, Xuanwen, Anastasov, Natasa, Wang, Yanfang, Rosemann, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889649/ https://www.ncbi.nlm.nih.gov/pubmed/31747912 http://dx.doi.org/10.1186/s12967-019-2126-6 |
Ejemplares similares
-
A novel 4-gene signature for overall survival prediction in lung adenocarcinoma patients with lymph node metastasis
por: Wang, Yanfang, et al.
Publicado: (2019) -
Somatic Super-Enhancer Epigenetic Signature for Overall Survival
Prediction in Patients with Breast Invasive Carcinoma
por: Yang, Xu, et al.
Publicado: (2023) -
Development and validation of a hypoxia-related gene signature to predict overall survival in early-stage lung adenocarcinoma patients
por: Sun, Jing, et al.
Publicado: (2020) -
A Novel Ferroptosis-Related Gene Signature Predicts Overall Survival of Breast Cancer Patients
por: Li, Haifeng, et al.
Publicado: (2021) -
A Novel Ferroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Breast Cancer
por: Zhu, Lizhe, et al.
Publicado: (2021)